A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood
第1相
完了
NCT05945888
| 対象疾患 | Healthy |
|---|
| 相 | 第1相 |
|---|
| スポンサー | Boehringer Ingelheim |
|---|
| ステータス | 完了 |
|---|
| 参加者数 | 68 名 |
|---|
| 介入（薬剤） | BI 3000202, Placebo matching BI 3000202 |
|---|
| 開始日 | 2023年7月25日 |
|---|
| 完了日 | 2023年11月13日 |
|---|
| 結果公開日 | 2026年6月8日 |
|---|
概要
The single rising dose (SRD) part of the trial investigates safety, tolerability, and pharmacokinetics of BI 3000202. The food effect (FE) part is conducted to assess the effect of food on the relative bioavailability of the BI 3000202 formulation.
SRD Part: Number of Any Treatment-emergent Adverse Event Assessed as Drug-related by the Investigator
From drug administration on Day 1 plus REP of 48 hours, up to 2 days. · Participants
| Single Rising Dose (SRD): Placebo Matching BI 3000202 | 1 Participants |
|---|
| SRD: Dose 1 - BI 3000202 | 0 Participants |
|---|
| SRD: Dose 2 - BI 3000202 | 0 Participants |
|---|
| SRD: Dose 3 - BI 3000202 | 1 Participants |
|---|
| SRD: Dose 4 - BI 3000202 | 0 Participants |
|---|
| SRD: Dose 5 - BI 3000202 | 0 Participants |
|---|
FE Part: Area Under the Concentration-time Curve of BI 3000202 in Plasma Over the Dosing Interval 0 to 24 Hours (AUC0-24)
Within 3 hours (h) prior to and 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 24, and 48 h after drug administration · Nanomoles times hour per Liter
| Food Effect (FE): Low Dose III BI 3000202 Fasted (= Reference R) | 901.43 ± NA Nanomoles times hour per Liter |
|---|
| FE Part: Low Dose III BI 3000202 Fed (= Test T) | 768.45 ± NA Nanomoles times hour per Liter |
|---|
| Geometric mean ratio (T/R) [%] | 85.25 (95% CI 71.74–101.30) |
|---|
FE Part: Maximum Measured Concentration of BI 3000202 in Plasma (Cmax)
Within 3 hours (h) prior to and 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 24, and 48 h after drug administration · Nanomoles per Liter
| Food Effect (FE): Low Dose III BI 3000202 Fasted (= Reference R) | 229.43 ± NA Nanomoles per Liter |
|---|
| FE Part: Low Dose III BI 3000202 Fed (= Test T) | 219.06 ± NA Nanomoles per Liter |
|---|
| Geometric mean ratio (T/R) [%] | 95.48 (95% CI 65.40–139.41) |
|---|
BENITIONS で見る
ClinicalTrials.gov の原文を見る
すべての治験
このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。